A new trading day began on Friday, with X4 Pharmaceuticals Inc (NASDAQ: XFOR) stock price up 5.85% from the previous day of trading, before settling in for the closing price of $3.51. XFOR’s price has ranged from $1.35 to $26.83 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 47.41% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 63.29%.
X4 Pharmaceuticals Inc (XFOR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of X4 Pharmaceuticals Inc is 8.77%, while institutional ownership is 27.90%. The most recent insider transaction that took place on Oct 23 ’25, was worth 249,997. In this transaction Executive Chairman of this company bought 86,206 shares at a rate of $2.90, taking the stock ownership to the 376,087 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Commercial Officer bought 1,032 for $2.48, making the entire transaction worth $2,561. This insider now owns 25,337 shares in total.
X4 Pharmaceuticals Inc (XFOR) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -6 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.82% during the next five years compared to 47.41% growth over the previous five years of trading.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Here are X4 Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.01, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -0.94 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.68 million. That was inferior than the volume of 1.5 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 27.40%.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 67.82%, which indicates a significant increase from 47.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was higher than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.40, while its 200-day Moving Average is $5.50. However, in the short run, X4 Pharmaceuticals Inc’s stock first resistance to watch stands at $3.89. Second resistance stands at $4.08. The third major resistance level sits at $4.39. If the price goes on to break the first support level at $3.39, it is likely to go to the next support level at $3.08. The third support level lies at $2.89 if the price breaches the second support level.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
With a market capitalization of 324.39 million, the company has a total of 11,408K Shares Outstanding. Currently, annual sales are 2,560 K while annual income is -37,450 K. The company’s previous quarter sales were 1,970 K while its latest quarter income was -25,740 K.
